RecruitingNCT07375602

A Multimodal AI Prediction Model for Complications After Transcatheter Closure of Perimembranous VSD in Children

Multimodal Clinical Data Integration and Artificial Intelligence Modeling for Predicting Complications Following Pediatric Transcatheter Closure of Perimembranous Ventricular Septal Defect

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Enrollment

5,249 participants

Start Date

Feb 1, 2026

Study Type

OBSERVATIONAL

Conditions

Postoperative Complications Cardiac Catheterization Congenital Heart Disease (CHD)Ventricular Septal Defects (VSD)

Summary

The goal of this observational study is to develop and validate a multimodal artificial intelligence prediction model for treatment-related complications in children with perimembranous ventricular septal defect (pmVSD) undergoing transcatheter device closure. The main question it aims to answer is: Can an AI model that integrates demographics, laboratory results, electronic health record text, echocardiography reports, chest radiographs, and electrocardiogram accurately predict the risk of complications at the individual patient level? Data will be retrospectively collected from routine clinical care records of pediatric patients who underwent transcatheter closure for pmVSD. Deep learning methods will be used to extract features from text and images to train and validate the prediction model.

Eligibility

Max Age: 18 Years

Inclusion Criteria3

Age ≤ 18 years at the time of transcatheter procedure.
Diagnosis of perimembranous ventricular septal defect confirmed by echocardiography, and underwent transcatheter device closure at the study center.
Medical records sufficient to ascertain the primary outcome within the pre-specified follow-up window, and availability of minimum baseline clinical information required for model development/validation.

Exclusion Criteria3

Ventricular septal defects not classified as perimembranous on echocardiography, including muscular, outlet, or inlet VSDs, as well as multiple or complex VSDs involving more than one septal region.
Presence of complex congenital heart disease or associated structural abnormalities requiring concomitant surgical repair (e.g., tetralogy of Fallot).
Prior surgical VSD repair or prior transcatheter VSD closure.

Interested in this trial?

Get notified about updates and connect with the research team.